Bayer Aktiengesellschaft
BAYN
Rangering i aksjer
#489
Bayer Aktiengesellschaft operates as a life science company in Europe, the... Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Aksjekurs
$50.31
Sist synkronisert: 2026-10-21
Markedsverdi
$49.43B
Endring (1 dag)
-2.45%
Endring (1 år)
57.43%
Land
DE
Handel Bayer Aktiengesellschaft (BAYN)
Kategori
Healthcare
EPS for Bayer Aktiengesellschaft (BAYN)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Bayer Aktiengesellschaft er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Bayer Aktiengesellschaft fra 2026 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $29.89 | - |
US
|
|
| $6.60 | - |
US
|
|
| $3.55 | - |
US
|
|
| $1.26 | - |
US
|
|
| $20.39 | - |
CH
|
